Ajinomoto Co Inc 2024 IR
The report highlights the Ajinomoto Group's strategic progress in co-creating social and economic value through its unique 'AminoScience' approach. In fiscal 2023, the company achieved record sales of 1,439.2 billion yen and a business profit of 147.6 billion yen, driven by strong performance in its overseas food products and frozen foods businesses. Key sustainability achievements include a 35% reduction in greenhouse gas emissions (Scope 1 and 2) compared to fiscal 2018 and reaching 0.94 billion consumers with nutritional touch-points. Additionally, the group expanded its healthcare portfolio by acquiring Forge Biologics, a gene therapy CDMO, to accelerate growth in advanced medical modalities.
Company: Ajinomoto Co Inc
Sector: Consumer Staples
Country: Japan
Year: 2024
Type: IR
Pages: 128
Ajinomoto Co Inc
Asv Report
The report highlights the Ajinomoto Group's strategic progress in co-creating social and economic value through its unique 'AminoScience' approach. In fiscal 2023, the company achieved record sales of 1,439.2 billion yen and a business profit of 147.6 billion yen, driven by strong performance in its overseas food products and frozen foods businesses. Key sustainability achievements include a 35% reduction in greenhouse gas emissions (Scope 1 and 2) compared to fiscal 2018 and reaching 0.94 billion consumers with nutritional touch-points. Additionally, the group expanded its healthcare portfolio by acquiring Forge Biologics, a gene therapy CDMO, to accelerate growth in advanced medical modalities.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Apr 1, 2023 - Mar 31, 2024
Fiscal Year
2023
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Women on Board
Net Zero Target
Employees